Location: Room 745, Dowling Hall
Date: November 15, 2022
Time: 6:00 pm to 8:30 pm
The biotech and life sciences industries are among fastest growing in Massachusetts and the United States and are ones in which Tufts Alumni have a particularly strong impact. As new technologies have permitted scientists to unlock genes and manipulate chemicals to develop life-changing and life-saving medicines, they have also raised challenging legal, economic, and ethical questions. Join the Tufts Lawyers Association for a stimulating discussion on the cutting edge of law, biotech, and life science featuring an illustrious panel of experts from various specialties in the field. Parking, food and drink will be provided.
Panelists for this event will include:
- Christopher Albert, E01, AG09, Principal, Hamilton Brook Smith Reynolds, P.C.
- Sandra S. Congdon, E97, EG99, Associate General Counsel, Tufts University
- Andrew J. Merken, A87, Partner, Co-Chair Life Sciences and Co-Chair Securities, Burns & Levinson, LLP
- Parid Sava, E09, Director, Business Development at Sarepta Therapeutics
Moderated by: Christopher R. Vaccaro, A81, Partner, Dalton & Finegold, LLP
Sponsored by Tufts Lawyers Association (TLA) New England
